Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Merit Medical Systems (MMSI) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Merit Medical Systems (MMSI) over the last 16 years, with Q3 2025 value amounting to $197.7 million.

  • Merit Medical Systems' Cost of Revenue rose 846.69% to $197.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $761.2 million, marking a year-over-year increase of 797.67%. This contributed to the annual value of $713.2 million for FY2024, which is 589.27% up from last year.
  • According to the latest figures from Q3 2025, Merit Medical Systems' Cost of Revenue is $197.7 million, which was up 846.69% from $198.0 million recorded in Q2 2025.
  • In the past 5 years, Merit Medical Systems' Cost of Revenue registered a high of $198.0 million during Q2 2025, and its lowest value of $137.0 million during Q1 2021.
  • Moreover, its 5-year median value for Cost of Revenue was $167.3 million (2023), whereas its average is $167.7 million.
  • Examining YoY changes over the last 5 years, Merit Medical Systems' Cost of Revenue showed a top increase of 1642.2% in 2021 and a maximum decrease of 194.79% in 2021.
  • Over the past 5 years, Merit Medical Systems' Cost of Revenue (Quarter) stood at $149.7 million in 2021, then rose by 6.13% to $158.9 million in 2022, then grew by 9.52% to $174.0 million in 2023, then increased by 4.71% to $182.2 million in 2024, then rose by 8.55% to $197.7 million in 2025.
  • Its last three reported values are $197.7 million in Q3 2025, $198.0 million for Q2 2025, and $183.3 million during Q1 2025.